Cargando…
THU279 Long duration Of CFTR Modulators Consistently Improve Glucose Metabolism Parameters In Patients With Cystic Fibrosis
Disclosure: A. Cohen: None. A. Mass: None. D. Zangen: None. M. Cohen-Cymberknoh: None. Background: Impaired glycemic control and consequently Cystic fibrosis Related Diabetes (CFRD) due to gradual pancreatic β-cell dysfunction is a common complication (upto 50% in adults) in patients with cystic fib...
Autores principales: | Cohen, Amitay, Mass, Alon, Zangen, David, Cohen-Cymberknoh, Malena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553758/ http://dx.doi.org/10.1210/jendso/bvad114.715 |
Ejemplares similares
-
THU294 Glucagon Like Peptide-1 Analogue Therapy In Obese Patients With Cystic Fibrosis Related Diabetes
por: Reddy Ankireddypalli, Anvitha, et al.
Publicado: (2023) -
PSUN279 Refractory Hypoglycemia in the Setting of Incidental Urothelial Carcinoma
por: Kennedy, Randol, et al.
Publicado: (2022) -
SUN-LB026 Do CFTR Modulators Treat Cystic Fibrosis-Related Diabetes?
por: Mehfooz, Ayesha, et al.
Publicado: (2019) -
THU372 Finasteride Induced Hyperglycemia
por: Bose, Vivek, et al.
Publicado: (2023) -
THU245 Association Between Sleep Duration And Incident Diabetes Mellitus In Healthy Subjects: A 12-year Longitudinal Cohort Study
por: Kim, Wonjin, et al.
Publicado: (2023)